Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2023

Open Access 01-12-2023 | Leukemia | Research

Mellitin peptide quantification in seasonally collected crude bee venom and its anticancer effects on myelogenous K562 human leukaemia cell line

Authors: Maher Obeidat, Ihab F. Al-khraisat, Da’san M. M. Jaradat, Bayan Y. Ghanim, Qasem M. Abdallah, Duaa Abu Arqoub, Duaa Sabbah, Ola M. Al-Sanabra, Tawfiq Arafat, Nidal A. Qinna

Published in: BMC Complementary Medicine and Therapies | Issue 1/2023

Login to get access

Abstract

Background

Apitherapy is an emerging field in cancer research, particularly in developing communities. The potency of Melittin (MEL), a major constituent in bee venom is accounted for the cytotoxic capacity against cancer cells. It is postulated that the genotype of bees and the time of venom collection influences its specific activity against certain types of cancer.

Method

Hereby, Jordanian crude bee venom (JCBV) was collected during different seasons of the year, specifically spring, summer and autumn and investigated for in vitro antitumour effects. Venom collected during springtime comprised the highest quantity of MEL in comparison to venom collected some other time. Springtime-collected JCBV extract and MEL were tested on an immortal myelogenous leukaemia cell line, namely K562 leukemic cells. Treated cells were examined for cell modality via flow cytometry analysis and cell death mediating gene expressions.

Results

Springtime-collected JCBV extract and MEL showed an IC50 of 3.7 ± 0.37 μg/ml and 1.84 ± 0.75 μg/ml, respectively. In comparison to JCBV and positive control, MEL-treated cells exhibited late apoptotic death with a moderate cellular arrest at G0/G1 and an increase of cell number at G2/M phase. Expression of NF-κB/MAPK14 axis was inhibited in MEL and JCBV-treated cells, as well as expression of c-MYC and CDK4. Moreover, marked upregulation in ABL1, JUN and TNF was observed. In conclusion, springtime-collected JCBV showed the highest content of MEL while both JCBV and pure MEL showed apoptotic, necrotic, and cell cycle arrest efficiency against K562 leukemic cells.

Conclusion

Integration of bee venom in chemotherapy needs more investigation and should be carefully translated into clinical use. During such translation, the correlation of bee genotype, collection time and concentration of MEL in CBV should be profiled.
Literature
1.
go back to reference Zhang S, Liu Y, Ye Y, Wang XR, Lin LT, Xiao LY, et al. Bee venom therapy: Potential mechanisms and therapeutic applications. Toxicon. 2018;15(148):64–73.CrossRef Zhang S, Liu Y, Ye Y, Wang XR, Lin LT, Xiao LY, et al. Bee venom therapy: Potential mechanisms and therapeutic applications. Toxicon. 2018;15(148):64–73.CrossRef
2.
go back to reference Jeong YJ, Choi Y, Shin JM, Cho HJ, Kang JH, Park KK, et al. Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells. Food Chem Toxicol. 2014;68:218–25.CrossRefPubMed Jeong YJ, Choi Y, Shin JM, Cho HJ, Kang JH, Park KK, et al. Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells. Food Chem Toxicol. 2014;68:218–25.CrossRefPubMed
3.
go back to reference Lim HN, Baek SB, Jung HJ. Bee venom and its peptide component Melittin suppress growth and migration of melanoma cells via inhibition of PI3K/Akt/mTOR and MAPK pathways. Molecules. 2019;24(5):929.CrossRefPubMedPubMedCentral Lim HN, Baek SB, Jung HJ. Bee venom and its peptide component Melittin suppress growth and migration of melanoma cells via inhibition of PI3K/Akt/mTOR and MAPK pathways. Molecules. 2019;24(5):929.CrossRefPubMedPubMedCentral
4.
go back to reference Choi KE, Hwang CJ, Gu SM, Park MH, Kim JH, Park JH, et al. Cancer cell growth inhibitory effect of bee venom via increase of death receptor 3 expression and inactivation of NF-kappa B in NSCLC cells. Toxins (Basel). 2014;6(8):2210–28.CrossRefPubMed Choi KE, Hwang CJ, Gu SM, Park MH, Kim JH, Park JH, et al. Cancer cell growth inhibitory effect of bee venom via increase of death receptor 3 expression and inactivation of NF-kappa B in NSCLC cells. Toxins (Basel). 2014;6(8):2210–28.CrossRefPubMed
5.
go back to reference Rady I, Siddiqui IA, Rady M, Mukhtar H. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett. 2017;28(402):16.CrossRef Rady I, Siddiqui IA, Rady M, Mukhtar H. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett. 2017;28(402):16.CrossRef
6.
go back to reference Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.CrossRefPubMed Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.CrossRefPubMed
7.
go back to reference Park SC, Kim JY, Shin SO, Jeong CY, Kim MH, Shin SY, et al. Investigation of toroidal pore and oligomerization by Melittin using transmission electron microscopy. Biochem Biophys Res Commun. 2006;343(1):222–8.CrossRefPubMed Park SC, Kim JY, Shin SO, Jeong CY, Kim MH, Shin SY, et al. Investigation of toroidal pore and oligomerization by Melittin using transmission electron microscopy. Biochem Biophys Res Commun. 2006;343(1):222–8.CrossRefPubMed
8.
go back to reference Tu WC, Wu CC, Hsieh HL, Chen CY, Hsu SL. Honeybee venom induces calcium-dependent but caspase-independent apoptotic cell death in human melanoma A2058 cells. Toxicon. 2008;52(2):318–29.CrossRefPubMed Tu WC, Wu CC, Hsieh HL, Chen CY, Hsu SL. Honeybee venom induces calcium-dependent but caspase-independent apoptotic cell death in human melanoma A2058 cells. Toxicon. 2008;52(2):318–29.CrossRefPubMed
9.
go back to reference Sisakht M, Mashkani B, Bazi A, Ostadi H, Zare M, Avval FZ, et al. Bee venom induces apoptosis and suppresses matrix metaloprotease-2 expression in human glioblastoma cells. Rev Bras. 2017;27(3):324–8. Sisakht M, Mashkani B, Bazi A, Ostadi H, Zare M, Avval FZ, et al. Bee venom induces apoptosis and suppresses matrix metaloprotease-2 expression in human glioblastoma cells. Rev Bras. 2017;27(3):324–8.
10.
go back to reference Duffy C, Sorolla A, Wang E, Golden E, Woodward E, Davern K, et al. Honeybee venom and Melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. npj Precision Oncol. 2020;4(1):24.CrossRef Duffy C, Sorolla A, Wang E, Golden E, Woodward E, Davern K, et al. Honeybee venom and Melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. npj Precision Oncol. 2020;4(1):24.CrossRef
11.
go back to reference Jo M, Park MH, Kollipara PS, An BJ, Song HS, Han SB, et al. Anti-cancer effect of bee venom toxin and Melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicol Appl Pharmacol. 2012;258(1):72–81.CrossRefPubMed Jo M, Park MH, Kollipara PS, An BJ, Song HS, Han SB, et al. Anti-cancer effect of bee venom toxin and Melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicol Appl Pharmacol. 2012;258(1):72–81.CrossRefPubMed
12.
go back to reference Raouf A, Zhao Y, To K, et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell. 2008;3(1):109–18.CrossRefPubMed Raouf A, Zhao Y, To K, et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell. 2008;3(1):109–18.CrossRefPubMed
14.
go back to reference Peart MJ, Smyth GK, van Laar RK, et al. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc Natl Acad Sci U S A. 2005;102(10):3697–702.CrossRefPubMedPubMedCentral Peart MJ, Smyth GK, van Laar RK, et al. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc Natl Acad Sci U S A. 2005;102(10):3697–702.CrossRefPubMedPubMedCentral
15.
go back to reference Ceremuga M, Stela M, Janik E, Gorniak L, Synowiec E, Sliwinski T, et al. Melittin-A Natural Peptide from Bee Venom Which Induces Apoptosis in Human Leukaemia Cells. Biomolecules. 2020;10(2):247.CrossRefPubMedPubMedCentral Ceremuga M, Stela M, Janik E, Gorniak L, Synowiec E, Sliwinski T, et al. Melittin-A Natural Peptide from Bee Venom Which Induces Apoptosis in Human Leukaemia Cells. Biomolecules. 2020;10(2):247.CrossRefPubMedPubMedCentral
16.
go back to reference Ghanim BY, Qinna NA. Nrf2/ARE axis signalling in hepatocyte cellular death. Molecular Biology Reports. 2022;(49):4039–53. Ghanim BY, Qinna NA. Nrf2/ARE axis signalling in hepatocyte cellular death. Molecular Biology Reports. 2022;(49):4039–53.
17.
go back to reference Keith DJ, Eshleman AJ, Janowsky A. Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane spanning proteins. Eur J Pharmacol. 2011;650(3):501–10.CrossRefPubMed Keith DJ, Eshleman AJ, Janowsky A. Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane spanning proteins. Eur J Pharmacol. 2011;650(3):501–10.CrossRefPubMed
18.
go back to reference Haas E, Stanley DW. Phospholipase A2. xPharm: The Comprehensive Pharmacology Reference. 2007 Jan 1;1–2. Haas E, Stanley DW. Phospholipase A2. xPharm: The Comprehensive Pharmacology Reference. 2007 Jan 1;1–2.
19.
go back to reference Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):1–21.CrossRef Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):1–21.CrossRef
20.
go back to reference Carrà G, Torti D, Crivellaro S, Panuzzo C, Taulli R, Cilloni D, et al. The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias. Oncotarget. 2016;7(40). Available from: www.impactjournals.com/oncotarget/ Carrà G, Torti D, Crivellaro S, Panuzzo C, Taulli R, Cilloni D, et al. The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias. Oncotarget. 2016;7(40). Available from: www.​impactjournals.​com/​oncotarget/​
21.
go back to reference Qin X, Hu L, Shi S nan, Chen X, Zhuang C, Zhang W, et al. The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ame-liorates acute kidney injury by targeting RIPK1 and RIPK3 kinases. Biochem Pharmacol. 2020;177:113947.CrossRefPubMed Qin X, Hu L, Shi S nan, Chen X, Zhuang C, Zhang W, et al. The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ame-liorates acute kidney injury by targeting RIPK1 and RIPK3 kinases. Biochem Pharmacol. 2020;177:113947.CrossRefPubMed
22.
go back to reference Sharma N, Magistroni V, Piazza R, Citterio S, Mezzatesta C, Khandelwal P, et al. BCR/ABL1 and BCR are under thetranscriptional control of the MYC oncogene. Mol Cancer. 2015;14:132.CrossRefPubMedPubMedCentral Sharma N, Magistroni V, Piazza R, Citterio S, Mezzatesta C, Khandelwal P, et al. BCR/ABL1 and BCR are under thetranscriptional control of the MYC oncogene. Mol Cancer. 2015;14:132.CrossRefPubMedPubMedCentral
23.
go back to reference Ma L, Xu Z, Wang J, Zhu Z, Lin G, Jiang L, et al. Matrine inhibits BCR/ABL mediated ERK/MAPK pathway in human leukemia cells. Oncotarget. 2017;8(65):108880–9.CrossRefPubMedPubMedCentral Ma L, Xu Z, Wang J, Zhu Z, Lin G, Jiang L, et al. Matrine inhibits BCR/ABL mediated ERK/MAPK pathway in human leukemia cells. Oncotarget. 2017;8(65):108880–9.CrossRefPubMedPubMedCentral
24.
go back to reference Tzifi F, Economopoulou C, Gourgiotis D, Ardavanis A, Papageorgiou S, Scorilas A. The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias. Adv Hematol. 2012;2012:524308.CrossRefPubMed Tzifi F, Economopoulou C, Gourgiotis D, Ardavanis A, Papageorgiou S, Scorilas A. The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias. Adv Hematol. 2012;2012:524308.CrossRefPubMed
25.
go back to reference Diederich M, Sobolewski C, Cerella C, Dicato M, Ghibelli L. The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. Int J Cell Biol. 2010;2010:215158.PubMedPubMedCentral Diederich M, Sobolewski C, Cerella C, Dicato M, Ghibelli L. The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. Int J Cell Biol. 2010;2010:215158.PubMedPubMedCentral
26.
go back to reference Shortt J, Johnstone RW. Oncogenes in cell survival and cell death. Cold Spring Harbor Perspectives in Biology. 2012;4(12)1-10. Shortt J, Johnstone RW. Oncogenes in cell survival and cell death. Cold Spring Harbor Perspectives in Biology. 2012;4(12)1-10.
27.
go back to reference Poole CJ, Zheng W, Lee H, Young D, Lodh A, Chadli A, et al. Targeting the MYC oncogene in burkitt lymphoma through HSP90 inhibition. Cancers (Basel). 2018;10(11):1–13.CrossRef Poole CJ, Zheng W, Lee H, Young D, Lodh A, Chadli A, et al. Targeting the MYC oncogene in burkitt lymphoma through HSP90 inhibition. Cancers (Basel). 2018;10(11):1–13.CrossRef
28.
go back to reference Kollmann K, Heller G, Ott RG, Scheicher R, Zebedin-Brandl E, Schneckenleithner C, et al. c-JUN promotes BCR-ABL-induced lymphoid leukemia by inhibiting methylation of the 5’ region of CDK6. Blood. 2011;117(15):4065–75.CrossRefPubMed Kollmann K, Heller G, Ott RG, Scheicher R, Zebedin-Brandl E, Schneckenleithner C, et al. c-JUN promotes BCR-ABL-induced lymphoid leukemia by inhibiting methylation of the 5’ region of CDK6. Blood. 2011;117(15):4065–75.CrossRefPubMed
29.
go back to reference Shaulian E. AP-1 - The Jun proteins: Oncogenes or tumor suppressors in disguise? Cell Signal. 2010;22(6):894–9.CrossRefPubMed Shaulian E. AP-1 - The Jun proteins: Oncogenes or tumor suppressors in disguise? Cell Signal. 2010;22(6):894–9.CrossRefPubMed
30.
go back to reference Gao X, Leone GW, Wang H. Cyclin D-CDK4/6 functions in cancer. Adv Cancer Res [Internet]. 2020;1(148):14. Gao X, Leone GW, Wang H. Cyclin D-CDK4/6 functions in cancer. Adv Cancer Res [Internet]. 2020;1(148):14.
31.
go back to reference de Graaf DC, Brochetto Braga MR, de Abreu RMM, Blank S, Bridts CH, De Clerck LS, et al. Standard methods for Apis mellifera venom research. J Apic Res. 2021;60(4):1–31.CrossRef de Graaf DC, Brochetto Braga MR, de Abreu RMM, Blank S, Bridts CH, De Clerck LS, et al. Standard methods for Apis mellifera venom research. J Apic Res. 2021;60(4):1–31.CrossRef
32.
go back to reference Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112–6.CrossRefPubMed Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112–6.CrossRefPubMed
33.
go back to reference Orellana E, Kasinski A. Sulforhodamine B (SRB) Assay in Cell Culture to Investigate Cell Proliferation. Bio-Protocol. 2016;6(21):e1984.CrossRefPubMed Orellana E, Kasinski A. Sulforhodamine B (SRB) Assay in Cell Culture to Investigate Cell Proliferation. Bio-Protocol. 2016;6(21):e1984.CrossRefPubMed
34.
go back to reference Ghanim B, Ahmad M, Abdallah Q, Qatouseh L, Qinna N. Modulation of NRF2/ARE pathway- and cell death-related genes during drug-induced liver injury. Human & Experimental Toxicology. 2021;40(12):2223-36. Ghanim B, Ahmad M, Abdallah Q, Qatouseh L, Qinna N. Modulation of NRF2/ARE pathway- and cell death-related genes during drug-induced liver injury. Human & Experimental Toxicology. 2021;40(12):2223-36.
35.
go back to reference Roy JG, McElhaney JE, Verschoor CP. Reliable reference genes for the quantification of mRNA in human T-cells and PBMCs stimulated with live influenza virus. BMC Immunol. 2020;21(1):4.CrossRefPubMedPubMedCentral Roy JG, McElhaney JE, Verschoor CP. Reliable reference genes for the quantification of mRNA in human T-cells and PBMCs stimulated with live influenza virus. BMC Immunol. 2020;21(1):4.CrossRefPubMedPubMedCentral
Metadata
Title
Mellitin peptide quantification in seasonally collected crude bee venom and its anticancer effects on myelogenous K562 human leukaemia cell line
Authors
Maher Obeidat
Ihab F. Al-khraisat
Da’san M. M. Jaradat
Bayan Y. Ghanim
Qasem M. Abdallah
Duaa Abu Arqoub
Duaa Sabbah
Ola M. Al-Sanabra
Tawfiq Arafat
Nidal A. Qinna
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Leukemia
Published in
BMC Complementary Medicine and Therapies / Issue 1/2023
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-023-03897-x

Other articles of this Issue 1/2023

BMC Complementary Medicine and Therapies 1/2023 Go to the issue